Accent Capital Management, LLC Bluebird Bio, Inc. Transaction History
Accent Capital Management, LLC
- $174 Billion
- Q3 2024
A detailed history of Accent Capital Management, LLC transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Accent Capital Management, LLC holds 1,000 shares of BLUE stock, worth $380. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,000
Previous 1,700
41.18%
Holding current value
$380
Previous $1.67 Million
68.92%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding BLUE
# of Institutions
157Shares Held
79.1MCall Options Held
506KPut Options Held
603K-
Black Rock Inc. New York, NY15.4MShares$5.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$3.98 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN6.39MShares$2.43 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny5.15MShares$1.96 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$1.78 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $29.3M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...